BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11042318)

  • 1. Does full-term pregnancy at a young age protect women against breast cancer through hCG?
    Rao CV
    Obstet Gynecol; 2000 Nov; 96(5 Pt 1):783-6. PubMed ID: 11042318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer.
    Lojun S; Bao S; Lei ZM; Rao CV
    Biol Reprod; 1997 Nov; 57(5):1202-10. PubMed ID: 9369188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation?
    Perrier d'Hauterive S; Berndt S; Tsampalas M; Charlet-Renard C; Dubois M; Bourgain C; Hazout A; Foidart JM; Geenen V
    Gynecol Obstet Invest; 2007; 64(3):156-60. PubMed ID: 17934312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotropin decreases proliferation and invasion of breast cancer MCF-7 cells by inhibiting NF-kappaB and AP-1 activation.
    Rao ChV; Li X; Manna SK; Lei ZM; Aggarwal BB
    J Biol Chem; 2004 Jun; 279(24):25503-10. PubMed ID: 15044447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential novel roles of luteinizing hormone and human chorionic gonadotropin during early pregnancy in women.
    Rao CV
    Early Pregnancy; 1997 Mar; 3(1):1-9. PubMed ID: 9265552
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective Effects of Human Chorionic Gonadotropin Against Breast Cancer: How Can We Use This Information to Prevent/Treat the Disease?
    Rao CV
    Reprod Sci; 2017 Aug; 24(8):1102-1110. PubMed ID: 28715966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversial role of human chorionic gonadotropin in the development of breast cancer and other types of tumors.
    Gehring C; Siepmann T; Heidegger H; Jeschke U
    Breast; 2016 Apr; 26():135-40. PubMed ID: 27017252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel perspective on the role of human chorionic gonadotropin during pregnancy and in gestational trophoblastic disease.
    Rodway MR; Rao CV
    Early Pregnancy; 1995 Sep; 1(3):176-87. PubMed ID: 9363249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua.
    Reshef E; Lei ZM; Rao CV; Pridham DD; Chegini N; Luborsky JL
    J Clin Endocrinol Metab; 1990 Feb; 70(2):421-30. PubMed ID: 1688865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal approach to breast cancer prevention.
    Russo IH; Russo J
    J Cell Biochem Suppl; 2000; 34():1-6. PubMed ID: 10762007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposed role for hCG in clinical obstetrics.
    Kurtzman JT; Wilson H; Rao CV
    Semin Reprod Med; 2001; 19(1):63-8. PubMed ID: 11394205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adrenal cortex hyperfunction due to LH/hCG.
    Carlson HE
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):46-50. PubMed ID: 17363138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and pathological relevance of human uterine LH/hCG receptors.
    Rao CV
    J Soc Gynecol Investig; 2006 Feb; 13(2):77-8. PubMed ID: 16443498
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel biological and possible applicable roles of LH/hCG receptor.
    Ziecik AJ; Kaczmarek MM; Blitek A; Kowalczyk AE; Li X; Rahman NA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):51-60. PubMed ID: 17367919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause.
    Papapetrou PD; Anagnostopoulos NI
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1187-95. PubMed ID: 3923023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues].
    Szajnik M; Nowak-Markwitz E; Szczepański MJ; Spaczyński M
    Ginekol Pol; 2007 Dec; 78(12):939-43. PubMed ID: 18411916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.
    Choi J; Smitz J
    Gynecol Endocrinol; 2014 Mar; 30(3):174-81. PubMed ID: 24283620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human chorionic gonadotropin (hCG) and prevention of breast cancer.
    Janssens JP; Russo J; Russo I; Michiels L; Donders G; Verjans M; Riphagen I; Van den Bossche T; Deleu M; Sieprath P
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):93-8. PubMed ID: 17386970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the glycan moiety of the rat ovarian luteinizing hormone/chorionic gonadotropin (CG) receptor and human CG for receptor-hormone interaction.
    Petäjä-Repo UE; Merz WE; Rajaniemi HJ
    Endocrinology; 1991 Mar; 128(3):1209-17. PubMed ID: 1999142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human chorionic gonadotropin decreases human breast cancer cell proliferation and promotes differentiation.
    Liao XH; Wang Y; Wang N; Yan TB; Xing WJ; Zheng L; Zhao DW; Li YQ; Liu LY; Sun XG; Hu P; Zhang TC
    IUBMB Life; 2014 May; 66(5):352-60. PubMed ID: 24753159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.